Vincere Biosciences is developing a therapy for Parkinson's disease. It is developing drugs that can restore mitochondrial quality to slow the progression of Parkinson’s disease and other age-related disorders where deficits in mitochondrial health are known to underlie the disease process. Its patented technology is inhibiting USP30 which accelerates the clearance of damaged mitochondria and reduces Parkinson's symptoms.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.